1. Shotgun metagenomics for microbiome and resistome detection in septic patients with urinary tract infection
- Author
-
Philippe Vignon, Olivier Barraud, Céline Ravry, Bruno François, Thomas Daix, Marie-Cécile Ploy, Anti-infectieux : supports moléculaires des résistances et innovations thérapeutiques (RESINFIT), CHU Limoges-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST), Université de Limoges (UNILIM)-Université de Limoges (UNILIM), Service de Réanimation Polyvalente [CHU Limoges], CHU Limoges, UMR INSERM 1092, Université of Limoges, and CCSD, Accord Elsevier
- Subjects
0301 basic medicine ,Microbiology (medical) ,medicine.drug_class ,[SDV]Life Sciences [q-bio] ,Urinary system ,030106 microbiology ,Cephalosporin ,Urine ,Microbiology ,Sepsis ,03 medical and health sciences ,0302 clinical medicine ,Antibiotic resistance ,Drug Resistance, Bacterial ,medicine ,Humans ,Pharmacology (medical) ,030212 general & internal medicine ,Microbiome ,Bacteria ,business.industry ,Bacterial Infections ,General Medicine ,medicine.disease ,DNA extraction ,Anti-Bacterial Agents ,3. Good health ,Resistome ,[SDV] Life Sciences [q-bio] ,Infectious Diseases ,Urinary Tract Infections ,Metagenomics ,business ,Genome, Bacterial - Abstract
In sepsis, early and appropriate antibiotic therapy is key but is frequently challenging due to the increasing incidence of multidrug-resistant bacteria. The feasibility of shotgun metagenomics (SM) has been scarcely assessed in urinary tract infections (UTIs). In this study, the feasibility of SM to detect both the microbiome and the resistome in patients with confirmed UTI-related sepsis was evaluated. Urine samples were obtained from 40 adult patients with UTI-related sepsis. Conventional culture was used as a reference. Following total DNA extraction and depletion of human DNA, SM was performed using Ion ProtonTM technology. Bioinformatics analysis was conducted using GeneiousⓇ software as well as online tools from the Center for Genomic Epidemiology. For the microbiome, SM was consistently concordant when urine culture was positive with only one bacterium (mainly Escherichia coli). For the resistome, results were in agreement with antimicrobial susceptibility testing with no major discrepancies. SM consistently identified blaCTX-M genes responsible for resistance to third-generation cephalosporins. Resistance to aminoglycosides and fluoroquinolones was identified in all patients. This pilot study confirms that SM can provide clinically relevant information both on the microbiome and the resistome from urine samples of patients with UTI-related sepsis.
- Published
- 2019
- Full Text
- View/download PDF